Huberman LabEssentials: Tools for Hormone Optimization in Males | Dr. Kyle Gillett
CHAPTERS
- 0:00 – 2:29
Baseline first: blood tests for testosterone, SHBG, and DHT balance
The discussion opens with the idea that male hormone optimization should start with objective diagnostics, much like running a full scan on a new car. Gillett explains why testosterone alone is insufficient and why SHBG (sex hormone binding globulin) and free testosterone/DHT context matter for understanding androgen activity.
- •Use blood work as the foundational “dashboard” for hormone health across lifespan
- •Measure testosterone plus SHBG (or free testosterone) for interpretability
- •SHBG binds androgens/estrogens and strongly shapes free vs. total hormone availability
- •DHT’s role in puberty/secondary sex characteristics and why balance matters
- •Typical follow-up lab cadence: ~6 months with shared decision-making
- 2:29 – 3:57
Diet foundations during development: dairy, IGF-1, vitamin D, and bone stockpiling
Gillett emphasizes diet as a primary pillar, especially during puberty through early adulthood, warning against removing supportive foods without reason. He highlights IGF-1’s role in growth and vitamin D’s contribution to testosterone production and skeletal development.
- •Diet changes (e.g., abruptly removing dairy) can reduce IGF-1 support during development
- •IGF-1 supports long bone growth, secondary sex characteristics, skin/hair growth
- •Vitamin D supports testosterone production and bone mineralization
- •Up to ~25 years, optimizing GH/IGF-1 supports bone density and growth
- •Adequate (not excessive) estrogen is part of building long-term bone resilience
- 3:57 – 4:37
Avoid extreme diets too early: risks of pure carnivore/vegan in teens and early 20s
Huberman asks about strict dietary patterns, and Gillett draws a clear line: extreme restriction in early years can impair free androgen levels. He suggests such diets may be less problematic later but calls them a poor idea during adolescence and early adulthood.
- •Pure carnivore or pure vegan patterns can be problematic in teens/early 20s
- •Risk: significant decreases in free androgens and reduced androgen receptor signaling
- •Late 20s may be a more plausible timeframe for experimenting with extremes
- •Balanced intake across food groups is positioned as broadly beneficial
- •Developmental stage should guide dietary aggressiveness
- 4:37 – 5:36
Fiber and the gut microbiome as a long-term hormone-adjacent lever
The conversation shifts to fiber as a foundational input that shapes the gut microbiome “set point.” Gillett frames prebiotic fiber as feeding beneficial microbes, influencing health trajectories across decades.
- •Fiber is “paramount” for establishing a durable gut microbiome baseline
- •Prebiotic fiber functions like “fish food” for beneficial microbes
- •Dietary inputs can skew microbiome toward beneficial vs. detrimental states
- •Importance extends across lifespan, with special relevance in teens–30s
- •Essential fatty acids and fiber are linked to ongoing brain development and health
- 5:36 – 6:44
Caloric restriction: when fat loss helps testosterone vs. when it suppresses it
Huberman revisits a key nuance: caloric deficits can improve testosterone if they reduce excess adiposity, but harm hormones in already-lean individuals. Gillett details mechanisms—reduced building blocks, more catabolism, lower IGF-1 signaling, and higher SHBG lowering free hormones.
- •Overweight individuals may see testosterone improve with gradual fat loss
- •Lean individuals often see testosterone drop under caloric restriction
- •Mechanisms: fewer hormone substrates, more catabolic signaling
- •Reduced GH/IGF-1 signaling and increased SHBG in caloric deficit
- •Free androgens/estrogens tend to decrease when SHBG rises
- 6:44 – 7:50
Lifestyle pillars beyond food: stress regulation and “purpose” as hormonal context
Gillett frames stress as a major disruptor that can unravel diet, exercise, and recovery behaviors. He adds a “spirit/purpose” pillar—self-actualization and goal-setting—as a practical framework that can evolve over time.
- •Stress can derail other pillars (diet, exercise, sleep behaviors)
- •Learning coping strategies is especially relevant in 20s–30s
- •Purpose/self-actualization supports consistent effort allocation
- •Purpose is dynamic: choose goals, reassess, then choose new ones
- •Psychological context is treated as part of endocrine optimization
- 7:50 – 8:59
Exercise programming for hormones: enough intensity, not too long
Gillett recommends a sustainable training structure: several vigorous sessions weekly plus additional low-intensity work. He cautions that regularly training vigorously for more than an hour is not hormonally supportive based on endurance-duration observations.
- •Sustainable template: 3–4 vigorous sessions/week
- •Add 3–4 additional less-vigorous sessions/week if desired
- •Avoid routinely doing >1 hour of vigorous training
- •Rating of perceived exertion is used in studies to define vigorous effort
- •Goal: long-term consistency without hormonal downsides from overreaching
- 8:59 – 11:10
TRT in young men: rarely justified when labs are normal
Huberman challenges the trend of young men using TRT despite normal levels. Gillett agrees it is almost never appropriate in the 20s except for rare medical conditions, emphasizing that benefit rarely outweighs fertility and health tradeoffs in young, eugonadal men.
- •TRT use in teens/20s with normal labs is generally a poor risk–benefit trade
- •Rare exceptions exist (e.g., specific congenital conditions)
- •Key concerns: fertility suppression and downstream management complexity
- •“Optimization” vs. true replacement is a critical distinction
- •Clinical decision should be driven by symptoms plus comprehensive evaluation
- 11:10 – 14:16
Core supplements: creatine, hair-loss concerns, and adding betaine
Gillett starts the supplement discussion with creatine, outlining performance and hormonal effects (small total T increase, more conversion to DHT). He addresses the hair-loss myth and explains when betaine is useful, especially in the context of elevated homocysteine.
- •Creatine: supports ATP buffering, oxidative stress, amino acid synthesis
- •Slight increase in total testosterone and conversion to DHT
- •Hair loss is not a good reason to avoid creatine; effects are not supraphysiologic
- •Betaine can help creatine “non-responders” and supports methionine/homocysteine handling
- •Betaine is mainly relevant if homocysteine is persistently elevated (verify via blood test)
- 14:16 – 17:23
L-carnitine: dosing, oral vs. injectable, TMAO risk, and mitigation with garlic/berberine
The episode dives into L-carnitine forms, absorption, and practical dosing ranges. Gillett flags TMAO concerns at high oral doses (especially with a dysregulated microbiome) and discusses mitigation strategies including allicin from garlic and sometimes berberine.
- •Injectable L-carnitine requires medical supervision; oral bioavailability is low (~10%)
- •Typical oral dose range: ~1–5 grams/day
- •High-dose carnitine/choline can increase TMAO depending on gut microbiota
- •Garlic (allicin) may reduce conversion to TMAO; berberine may also help but has side effects for some
- •L-carnitine shuttles nutrients into mitochondria and may increase androgen receptor density
- 17:23 – 19:15
No need to cycle basics + vitamin D and boron for SHBG management
Huberman asks about cycling, and Gillett says there’s no clear need for cycling creatine, betaine, or L-carnitine. They then cover vitamin D as a sterol hormone and boron as a tool to acutely lower high SHBG, including dose ranges and geographic/soil considerations.
- •No compelling reason to cycle creatine, betaine, or L-carnitine
- •Vitamin D deficiency correction can improve testosterone
- •Boron may acutely lower SHBG (typical: ~5–12 mg/day)
- •Effect may not be sustained; use strategically rather than expecting permanence
- •Boron content varies by soil/region; may partly explain population reference-range differences
- 19:15 – 22:01
Herbal tools for steroidogenesis: tongkat ali dosing, standardization, and who benefits most
Gillett explains tongkat ali (longjack) as a steroidogenesis cascade modulator and encourages understanding cholesterol-derived hormone pathways. He gives a broad dosing range and stresses standardization (eurycomanone content), noting it can be especially helpful when growth signals (insulin/IGF-1) are lower.
- •Tongkat ali supports multiple steps in testosterone synthesis from cholesterol pathways
- •Suggested range: ~300–1,200 mg/day depending on extract potency
- •Standardization matters; eurycomanone is a key active compound
- •May be more impactful during caloric deficit/lower-carb states with lower insulin/IGF-1
- •Can increase total/free testosterone and sometimes DHEA; may reduce SHBG when SHBG is high
- 22:01 – 23:56
Fadogia agrestis: LH support, toxicity signals, and conservative dosing approaches
They discuss fadogia as a plant-based tool that can increase pituitary LH release and thereby testosterone output. Gillett reviews rat toxicity signals (without antioxidants), suggests lab monitoring, and provides a conservative “safe” human-equivalent dosing strategy.
- •Fadogia agrestis may increase luteinizing hormone (LH) release
- •LH stimulates Leydig cells to produce testosterone (conceptually similar pathway to hCG)
- •Rat data suggest possible inflammatory/toxicity markers (GGT, alkaline phosphatase) at higher doses
- •Conservative human guidance: ~300 mg/day; alternative: 600 mg every other day or M/W/F
- •Monitor labs/markers if using; human risk may differ from rodent data
- 23:56 – 28:32
Testosterone therapy mechanics: dosing frequency, SHBG considerations, and side effects to monitor
Huberman and Gillett move into practical testosterone therapy parameters, emphasizing smaller, more frequent dosing and individualization by SHBG/free T. They outline common starting weekly doses and a wide set of potential adverse effects spanning skin, mood, cardiovascular markers, fertility, and lipids—underscoring physician oversight.
- •Dosing depends on SHBG and free testosterone, not total T alone
- •Common starting range: ~100–120 mg/week split 2–3x/week (cypionate/enanthate)
- •More frequent dosing can reduce peaks/troughs vs. infrequent large injections
- •Potential issues: acne/skin changes, hair loss, mood/mania risk, lipid/ApoB changes, hematology changes, fertility suppression
- •Requires broad monitoring and ideally interdisciplinary medical oversight
- 28:32 – 31:06
Clomiphene (SERM): mechanism, why it’s usually not a long-term optimization strategy
The conversation addresses clomiphene use as an alternative to exogenous testosterone. Gillett explains it blocks estrogen feedback at the hypothalamus/pituitary to raise LH/FSH and testosterone, but stresses that systemic receptor effects and side effects (including visual issues) make long-term use unattractive in most cases.
- •Clomiphene increases testosterone dose-dependently by blocking estrogen feedback centrally
- •SERMs have tissue-selective receptor actions across the body (complex receptor biology)
- •Side effects are common; visual changes can occur via eye receptor interactions
- •Positioned mainly as a temporary measure in select cases, not routine long-term therapy
- •“Optimization” use is generally not clinically justified for most individuals
- 31:06 – 31:58
Alcohol and aromatase: dose-dependent testosterone suppression and calorie burden
Huberman asks whether alcohol increases aromatase, and Gillett answers yes, significantly and dose-dependently. He also notes alcohol’s caloric load and GABAergic effects that can reduce LH/FSH signaling, further lowering testosterone—similar in some ways to opioid effects.
- •Alcohol increases aromatase activity and does so dose-dependently
- •Practical guidance: avoid frequent/high intake; limit heavy episodes (e.g., a few standard drinks)
- •Alcohol is calorie-dense (7 kcal/gram), complicating body composition goals
- •GABAergic effects can reduce LH/FSH release and suppress testosterone
- •Hormonal impact is both direct (aromatase) and indirect (neuroendocrine signaling)
- 31:58 – 33:59
Prostate and sleep support: low-dose tadalafil for nocturia, blood flow, and androgen receptor density
Gillett describes tadalafil (Cialis) as an underappreciated medication with multiple uses beyond erectile dysfunction, including modest blood pressure effects and prostate-related benefits. He highlights its potential to reduce nighttime urination and thereby improve sleep, indirectly supporting growth hormone and testosterone.
- •Low-dose tadalafil commonly: ~2.5–5 mg/day; generally avoid >10 mg/day unless indicated
- •Can slightly lower blood pressure; higher doses may affect red/green color discrimination (reversible)
- •May improve nocturia, often cutting nighttime urination episodes in half
- •Better sleep can secondarily support growth hormone and testosterone
- •Tadalafil may increase androgen receptor density (similar to L-carnitine)
- 33:59 – 36:17
Hair loss strategies: topical antiandrogens, finasteride/dutasteride nuances, and systemic spillover
The episode closes with hair-loss interventions and how they intersect with DHT and male vigor. Gillett outlines topical options (ketoconazole, caffeine), warns about systemic absorption (notably spironolactone), and differentiates topical finasteride vs. topical dutasteride in terms of systemic DHT reduction.
- •Some DHT-blocking strategies can reduce libido/motivation/vigor in susceptible individuals
- •Topical antiandrogens: ketoconazole and caffeine may be modestly helpful
- •Avoid topical spironolactone in men unless specifically prescribed (systemic absorption risk)
- •Topical finasteride can lower systemic DHT ~30% in many cases
- •Topical dutasteride may have minimal systemic DHT impact anecdotally due to pharmacokinetics at low/topical dosing
